Development of Potent and Selective Inhibitors for Group VIA Calcium-Independent Phospholipase A<sub>2</sub> Guided by Molecular Dynamics and Structure–Activity Relationships
作者:Varnavas D. Mouchlis、Dimitris Limnios、Maroula G. Kokotou、Efrosini Barbayianni、George Kokotos、J. Andrew McCammon、Edward A. Dennis
DOI:10.1021/acs.jmedchem.6b00377
日期:2016.5.12
The development of inhibitors for phospholipase A2 (PLA2) is important in elucidating the enzymes implication in various biological pathways. PLA2 enzymes are an important pharmacological target implicated in various inflammatory diseases. Computational chemistry, organic synthesis, and in vitro assays were employed to develop potent and selective inhibitors for group VIA calcium-independent PLA2.
磷脂酶A 2(PLA 2)抑制剂的开发对于阐明酶在各种生物学途径中的意义很重要。PLA 2酶是与多种炎性疾病有关的重要药理靶标。计算化学,有机合成和体外测定法被用来为VIA组钙独立的PLA 2开发有效的和选择性的抑制剂。研究了一组氟酮抑制剂与两种人胞质PLA 2酶(IVA cPLA 2组和VIA iPLA 2组)的结合方式。合成了新化合物,并针对三种主要PLA 2进行了分析s。这项研究导致了针对GVIA iPLA 2的四种有效的和选择性的硫醚氟代酮抑制剂以及硫醚酮1,2,4-恶二唑抑制剂的开发,它们将作为未来开发和研究的先导化合物。具有硫醚的1,2,4-恶二唑酮官能团是一种新颖的结构,它将被用作开发具有更高效力和对GVIA iPLA 2选择性的抑制剂的先导。